MSP Recovery Total Long Term Liabilities 2020-2025 | MSPR

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

MSP Recovery total long term liabilities from 2020 to 2025. Total long term liabilities can be defined as the sum of all non-current liabilities.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

MSP Recovery total long term liabilities from 2020 to 2025. Total long term liabilities can be defined as the sum of all non-current liabilities.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$47.5B
Tempus AI (TEM)	$14B
Doximity (DOCS)	$12.7B
Hims & Hers Health (HIMS)	$10.1B
IRhythm Technologies (IRTC)	$5.4B
Hinge Health (HNGE)	$4.5B
Inspire Medical Systems (INSP)	$2.8B
Privia Health (PRVA)	$2.7B
Heartflow (HTFL)	$2.4B
Enovis (ENOV)	$1.8B
10x Genomics (TXG)	$1.8B
Phreesia (PHR)	$1.8B
Omnicell (OMCL)	$1.5B
Schrodinger (SDGR)	$1.5B
Azenta (AZTA)	$1.4B
Clover Health Investments (CLOV)	$1.4B
Claritev (CTEV)	$1.2B
Evolent Health (EVH)	$1.1B
Fulgent Genetics (FLGT)	$666M
Zepp Health (ZEPP)	$580M
Veradigm (MDRX)	$525M
Standard BioTools (LAB)	$485M
Talkspace (TALK)	$469M
Butterfly Network (BFLY)	$383M
Carlsmed (CARL)	$346M
TruBridge (TBRG)	$307M
Outset Medical (OM)	$252M
SOPHiA GENETICS SA (SOPH)	$244M
Health Catalyst (HCAT)	$231M
Nyxoah SA (NYXH)	$219M